• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Archive by Topic » News

The Genealogy of Blood Cells

Hematopoietic stem cells (HSCs) give rise to all types of blood cells through myeloid progenitor cell types (e.g., red blood…

January 31, 2024

Pathogenesis of Antibody-Mediated TRALI by Complement

Transfusion-related acute lung injury (TRALI) is a rare, life-threatening adverse transfusion reaction that is difficult to predict and treat. The…

January 25, 2024

Prediction of Vasovagal Reactions in Whole Blood Donors Using a Scoring System

Previous studies have identified risk factors for vasovagal reactions (VVRs) in blood donors, including young age, female sex, lower body…

January 17, 2024

Deep Learning A.I. System for Platelet Management

Platelet inventory management is challenging due to their short shelf-life and fluctuating demand.  Researchers in Germany created a risk assessment…

January 10, 2024

Low Alloimmunization Risk if No Antibodies Formed during First 20 RBC Transfused Units

RBC transfusions are critical for many patients with sickle cell disease.  Patients are at risk, however, of developing alloantibodies, which…

January 4, 2024

Thalidomide Reduces Bleeding and Blood Transfusions in Patients with Small-Intestinal Angiodysplasia

Small-intestinal angiodysplasia (SIA), characterized by vascular malformation in the GI tract, is the most common cause of recurrent bleeding in…

December 27, 2023

Variability of Blood Donor Incentives Globally

Although the WHO recommends that blood collection establishments (BCEs) rely on voluntary, non-remunerated donations, a new study recently published by…

December 20, 2023

Safety of Platelet and Plasma Transfusions in the COVID-19 Era

By September 2022, 96% of U.S. blood donors had antibodies to SARS-CoV-2 due to infection and/or vaccination.  Some patient advocacy…

December 13, 2023

Darbepoetin Alfa Reduces RBC Transfusions in Infants with HDFN Treated with Intrauterine Transfusions

Hemolytic disease of the fetus and newborn (HDFN) is a severe disorder caused by maternal antibodies against fetal RBC antigens…

December 6, 2023

Novel Technology-Enabled Personalized Nomogram Increases Plasma Yield from Donations

Beginning in 1992, the U.S. has used a standard weight-based nomogram to guide appropriate plasma collection targets—15% to 42% of…

November 29, 2023

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Interim pages omitted …
  • Page 66
  • Go to Next Page »

Primary Sidebar

Latest News

  • Costs of Type & Screen and Crossmatch Laboratory Tests for RBCs Higher in U.S. Compared to U.K.

  • Gene Editing of HBG1 and HBG2 Promotors to Treat β-Thalassemia and Sickle Cell Disease

  • Jehovah’s Witness Governing Body Allows Autologous Transfusions

  • RBC Exchange Transfusion for Patients with Severe Babesiosis

    Question of the Day

    Copyright © 2026 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley